Mark O'Connor
4Patents
2h-index
18Co-inventors
45Inventor score
Filing activity: May 26, 1999 → Dec 21, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8143241B2 | DNA damage repair inhibitors for treatment of cancer | Emerging Cross-Sectional Technologies | 12 | Active |
| US7049313B2 | ATM inhibitors | Chemistry; Metallurgy | 6 | Expired |
| US12007393B2 | Methods based on the detection of RAD51 foci in tumor cells | Physics | 0 | Active |
| US6864054B1 | Polypeptides from CREB binding protein and related protein p300 for use in transcriptional regulation | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.